Prevalence of Factor H–Binding Protein Variants and NadA among Meningococcal Group B Isolates from the United States: Implications for the Development of a Multicomponent Group B Vaccine

Lignende værker

• Rapid Genetic Grouping of Factor H-Binding Protein (Genome-Derived Neisserial Antigen 1870), a Promising Group B Meningococcal Vaccine Candidate
  af: Beernink, Peter T., et al.
  Udgivet: (2006)
• Review of Meningococcal Group B Vaccines
  af: Granoff, Dan M.
  Udgivet: (2010)
• Transcriptional Regulation of the nadA Gene in Neisseria meningitidis Impacts the Prediction of Coverage of a Multicomponent Meningococcal Serogroup B Vaccine
  af: Fagnocchi, Luca, et al.
  Udgivet: (2013)
• Meningococcal Factor H–Binding Protein Variants Expressed by Epidemic Capsular Group A, W-135, and X Strains from Africa
  af: Beernink, P. T., et al.
  Udgivet: (2009)
• Immunity to Neisseria meningitidis Group B in Adults despite Lack of Serum Bactericidal Antibody
  af: Welsch, Jo Anne, et al.
  Udgivet: (2007)